We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

64 hedge funds and large institutions have $33.2M invested in Niagen Bioscience in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 8

38% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 16

20% more capital invested

Capital invested by funds: $27.7M → $33.2M (+$5.45M)

10% more funds holding

Funds holding: 58 → 64 (+6)

4.26% more ownership

Funds ownership: 12.04% → 16.3% (+4.3%)

Holders
64
Holders Change
+6
Holders Change %
+10.34%
% of All Funds
1.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
22
Increased
17
Reduced
8
Closed
16
Calls
$280K
Puts
–
Net Calls
+$280K
Net Calls Change
-$105K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.74M
2
State Street
State Street
Massachusetts
+$1.92M
3
TCM
Tieton Capital Management
Washington
+$1.32M
4
JMPWA
JP Morgan Private Wealth Advisors
California
+$1.02M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$920K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$2.12M
2
Goldman Sachs
Goldman Sachs
New York
-$964K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$772K
4
BCM
BlueCrest Capital Management
Jersey
-$523K
5
Invesco
Invesco
Georgia
-$427K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIA
51
OneDigital Investment Advisors
Kansas
$15K – – –
PCA
52
Peddock Capital Advisors
Massachusetts
$13K – – –
AIP
53
Ameritas Investment Partners
Nebraska
$12K +$12.6K +3,310 New
HS
54
Horan Securities
United States
$9K – – –
CPA
55
Cowen Prime Advisors
New York
$8K +$8.36K +2,200 New
MAM
56
Meeder Asset Management
Ohio
$5.55K +$5.68K +1,495 New
BNP Paribas Financial Markets
57
BNP Paribas Financial Markets
France
$4.7K +$4.78K +1,258 +15,725%
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$3K +$615 +162 +33%
TRCT
59
Tower Research Capital (TRC)
New York
$3K +$3.17K +835 New
RE
60
RBC Europe
United Kingdom
$2.86K – – –
AA
61
AlphaMark Advisors
Kentucky
$2K – – –
VFA
62
Valeo Financial Advisors
Indiana
$2K – – –
PIA
63
Piedmont Investment Advisors
North Carolina
$2K +$2.54K +668 New
Bank of Montreal
64
Bank of Montreal
Ontario, Canada
$1K +$1.04K +273 New
Millennium Management
65
Millennium Management
New York
– -$2.12M -504,525 Closed
Goldman Sachs
66
Goldman Sachs
New York
– -$964K -229,405 Closed
BCM
67
BlueCrest Capital Management
Jersey
– -$523K -124,510 Closed
TEE
68
Tibra Equities Europe
United Kingdom
– -$320K -76,158 Closed
LCM
69
Laurion Capital Management
New York
– -$297K -70,667 Closed
Squarepoint
70
Squarepoint
New York
– -$233K -55,450 Closed
RJA
71
Raymond James & Associates
Florida
– -$168K -40,001 Closed
ECM
72
Element Capital Management
New York
– -$155K -36,860 Closed
PAG
73
Private Advisor Group
New Jersey
– -$87K -20,750 Closed
BRWA
74
B. Riley Wealth Advisors
Florida
– -$59K -14,000 Closed
JG
75
Jefferies Group
New York
– -$59K -14,000 Closed
1 2
3
4

NAGE Hedge Fund Activity: Q2 2018 in Review

64 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q2 2018, worth a combined $33.2M — up 20% from $27.7M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new NAGE positions and 16 closed out — a net gain of 6 holders — while 17 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $6.74M. The largest seller was Millennium Management, exiting entirely with an estimated $2.12M sold.

  • 64 institutional investors held Niagen Bioscience (NAGE) as of Q2 2018, up from 58 in Q1 2018.
  • Funds reported $33.2M of Niagen Bioscience stock for Q2 2018, up 20% quarter-over-quarter.
  • 22 funds opened new Niagen Bioscience positions in Q2 2018 and 16 closed out, a net change of +6 holders.
  • The largest Niagen Bioscience buyer in Q2 2018 was BlackRock, an estimated $6.74M added.
  • The largest Niagen Bioscience seller in Q2 2018 was Millennium Management, an estimated $2.12M sold.

Based on aggregated 13F filings for Q2 2018.